VERV
Verve Therapeutics Inc
$7.31
Earnings Summary
Revenue | $5.14Mn |
Net Profits | $-48.35Mn |
Net Profit Margins | -939.97% |
Highlights
Verve Therapeutics Inc’s revenue jumped 408.3% since last year same period to $5.14Mn in the Q4 2023. On a quarterly growth basis, Verve Therapeutics Inc has generated 65.03% jump in its revenue since last 3-months.
Verve Therapeutics Inc’s net profit fell -17.69% since last year same period to $-48.35Mn in the Q4 2023. On a quarterly growth basis, Verve Therapeutics Inc has generated -5.67% fall in its net profits since last 3-months.
Verve Therapeutics Inc’s net profit margin jumped 76.85% since last year same period to -939.97% in the Q4 2023. On a quarterly growth basis, Verve Therapeutics Inc has generated 35.97% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Verve Therapeutics Inc post its latest quarter earnings
EPS Estimate Current Quarter | -0.83 |
EPS Estimate Current Year | -0.83 |
Highlights
Verve Therapeutics Inc’s earning per share (EPS) estimates for the current quarter stand at -0.83 - a -1.02% fall from last quarter’s estimates.
Verve Therapeutics Inc’s earning per share (EPS) estimates for the current year stand at -0.83.
Key Ratios
Key ratios of the Verve Therapeutics Inc post its Q1 2024 earnings
Earning Per Share (EPS) | 0 |
Highlights
Verve Therapeutics Inc’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q1 2024. This indicates that the Verve Therapeutics Inc has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2024-05-07 | -0.83 | 0 | 100% |
₹0 US Stocks a/c Opening Fee